Rena May serves as the Senior Director of Oncology Clinical Development at GSK, a position held since 2022. Previously, Rena worked as the Global Development Lead at Shanghai Junshi Biosciences Co Ltd from 2021 to 2022, and as Senior Director and Clinical Scientist in Late Stage Oncology at AstraZeneca from 2015 to 2021. Rena's clinical operations experience includes roles as Associate Director at Amplimmune, Inc. and Director of Clinical Research and Development at its subsidiary, MedImmune/AstraZeneca, from 2010 to 2015. Earlier, Rena undertook a research fellowship at Memorial Sloan Kettering Cancer Center from 2003 to 2006 and earned a PhD in Cell Biology and Immunology from the Albert Einstein College of Medicine of Yeshiva University in 2003. Rena also serves as Principal at RandA Clinical Research and Consulting since 2018.
This person is not in any teams
This person is not in any offices